About Remedix
Remedix is a Healthcare company based in Friedrichsdorf (Germany) founded in 2016, and was acquired by Axicorp in February 2016. Narcotic analgesics are distributed by Remedix across Europe. Its focus areas include Pharmaceutical Distributors and Specialty Drugs. Its competitors include GELITA and Life Radiopharma.
Company details
Remedix was founded in 2016 and is located in Friedrichsdorf, Germany. Operations are focused on the distribution of narcotic analgesics within the pharmaceutical sector. Services include supply chain management for controlled substances, serving healthcare providers and pharmacies primarily in the European market. The company is owned by John Dale and maintains its online presence through the domain remedix.eu. Activities adhere to regulatory standards for handling narcotics.
- Headquarters Friedrichsdorf, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website remedix.eu
- Acquired by Axicorp (Feb 2016)
Investors in Remedix
Remedix has secured backing from 1 investor. Prominent investors backing the company include Axicorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
OTC drugs are manufactured by Axicorp in Germany. | 2002 | axicorp.de | Friedrichsdorf, Germany |
Investor details for Remedix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Remedix
1 people are tracked at Remedix (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Dale | Owner | Leadership |
Complete people profiles for Remedix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Remedix
2 dated milestones of Remedix, from founding to its latest funding, stage changes and deals.
- Founded Remedix is founded.
- Exit Acquired by Axicorp.
Competitors of Remedix
Remedix has 2 listed competitors in our database. They include GELITA and Life Radiopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gelita.com | 1875 | Eberbach, Germany | 337 | Distributes pharmaceutical products to businesses and partners. | ||
| liferadiopharma.com | 2018 | Munsing, Germany | Supplies short-lived radiotracers for nuclear medical diagnostics and reliable delivery services. |
Detailed competitors of Remedix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Remedix
Remedix was founded in 2016.
Remedix is headquartered in Friedrichsdorf, Germany. It is registered at Friedrichsdorf, Hessen, Germany.
Remedix was founded in 2016 and is located in Friedrichsdorf, Germany. Operations are focused on the distribution of narcotic analgesics within the pharmaceutical sector. Services include supply chain management for controlled substances, serving healthcare providers and pharmacies primarily in the European market. The company is owned by John Dale and maintains its online presence through the domain remedix.eu. Activities adhere to regulatory standards for handling narcotics.
Remedix's top competitors include GELITA and Life Radiopharma.
Remedix has 1 investor. Key investors include Axicorp.
Yes. Remedix was acquired by Axicorp in February 2016.